Korea vs Sweden: Reported rate of new cervical cancer cases
Korea
8.86 per 100,000 women
in 2017
Sweden
7.48 per 100,000 women
in 2022
Korea rank
22nd
Sweden rank
25th
Reported rate of new cervical cancer cases over time
- Korea
- Sweden
How they compare
Korea currently reports 8.86 per 100,000 women against 7.48 per 100,000 women in Sweden, a difference of 1.38 per 100,000 women.
That makes Korea's figure about 1.2 times Sweden's.
The two have swapped places 1 time across 19 shared years of data; in 1999 it was Korea ahead.
Korea ranks 22nd and Sweden ranks 25th of 46 countries.
Korea has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Korea | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 16.27 per 100,000 women | 6.93 per 100,000 women | 9.34 per 100,000 women | Korea |
| 2000s | 13.03 per 100,000 women | 7 per 100,000 women | 6.03 per 100,000 women | Korea |
| 2010s | 9.64 per 100,000 women | 8.16 per 100,000 women | 1.49 per 100,000 women | Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, Korea or Sweden?
- Korea, at 8.86 per 100,000 women against 7.48 per 100,000 women in Sweden as of 2017.
- What is the difference in reported rate of new cervical cancer cases between Korea and Sweden?
- 1.38 per 100,000 women, with Korea ahead.
- How many years of comparable data are there for Korea and Sweden?
- 19 years are reported by both, from 1999 to 2017.
- How do Korea and Sweden rank globally for reported rate of new cervical cancer cases?
- Korea ranks 22nd and Sweden ranks 25th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) β processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.